Excerpt: “We write to request that the Committee on Energy and Commerce hold a hearing to review legislative initiatives aimed at improving federally-sanctioned research on cannabis, such as H.R. 171, Legitimate Use of Medicinal Marihuana Act (LUMMA); H.R. 601, Medical Cannabis Research Act of 2019; and H.R.3797, Medical Marijuana Research Act of 2019. It is critical that the Committee review the current state of cannabis research and hear from the U.S. Drug Enforcement Administration (DEA), the U.S. Food and Drug Administration (FDA), and the National Institute on Drug Abuse (NIDA),” write Walden, Burgess, Rodgers, and Griffith.
Click here to read the letter.